Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children
Clinical trial NCT00360230 · COMPLETED
Trial details
- NCT number
- NCT00360230
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-30
- Primary completion
- 2007-08-25
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.